Efficacy and Safety of LigaSure in Breast Surgery With Axillary Lymph Node Dissection in Patients With Breast Cancer: A Systematic Review and Meta-Analysis
- 2 December 2024
- journal article
- research article
- Published by SAGE Publications in Surgical Innovation
- Vol. 32 (2) , 155-164
Abstract
Background: Conventional axillary lymph node dissection (ALND) is associated with significant post-operative morbidity in patients undergoing breast surgery due to increased lymphatic leakage. LigaSure, an electrothermal bipolar vessel sealing system, provides better closure of the leakage. This study aims to compare the efficacy and safety of LigaSure against conventional techniques in patients with breast cancer underwent ALND and breast surgery. Methods: We conducted a comprehensive search across the databases to identify relevant studies. The search results were imported into Covidence for article eligibility screening, and all relevant outcomes data were synthesized using odd ratios (ORs) or standardized mean differences (SMDs) with 95% confidence intervals (CIs) in meta-analysis models using RevMan 5.4. Results: Twelve studies with the total of 895 patients (LigaSure = 441; Conventional technique = 454) with breast cancer underwent breast surgery with ALND were included. LigaSure was associated with significantly lower post-operative drain volume (SMD: −0.39, 95% CI [-0.53, −0.24], P < 0.00001), shortened duration of drain (SMD: −0.51, 95% CI [-0.67, −0.34], P < 0.00001), and reduced hospital stay length (SMD: −0.57, 95% CI [-0.96, −0.18], P = 0.004) compared to conventional techniques. However, no difference observed in total operation time, intra-operative blood loss, seroma related outcomes and post-operative complications between the two groups. Conclusion: LigaSure significantly reduced the lymphorrhea, duration of drain and hospital stay, however, it did not prove be effective in seroma-related outcomes.Keywords
This publication has 27 references indexed in Scilit:
- Total Sealing Technique (TST) with a bipolar vessel sealing system reduces lymphorrhea and seroma formation for axillary lymph node dissection in primary breast cancerSurgery Open Science, 2024
- Factors delaying chemotherapy in patients with breast cancer at a safety-net hospitalJournal of the National Medical Association, 2022
- Short length of stay and the discharge process: Preparing breast cancer patients appropriatelyPatient Education and Counseling, 2019
- Assessing risk of bias in a randomized trial2019
- Morbidity reduction using the vessel sealing device LigaSure™ in breast cancer surgeryEuropean Surgery, 2015
- Axillary lymphadenectomy for breast cancer. A randomized controlled trial comparing a bipolar vessel sealing system to the conventional techniqueThe Breast, 2012
- Electrothermal bipolar vessel sealing system in axillary dissection: A prospective randomized clinical studyInternational Journal of Surgery, 2011
- Seroma Formation after Mastectomy: Pathogenesis and PreventionIndian Journal of Surgical Oncology, 2010
- Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trialThe Lancet Oncology, 2010
- LigaSure Precise® use in thyroid operations: a comparison with the conventional methodEuropean Surgery, 2007